Legalize / European Union / Implementing Regulation

Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest Text with EEA relevance

Type Implementing Regulation

Publication 2012-07-26

State In force

Department European Commission

Source EUR-Lex

Article 1

For the purposes of the renewal procedure, the evaluation of each active substance set out in the first column of the Annex is allocated either to a rapporteur Member State, as set out in the second column of that Annex, and to a co-rapporteur Member State, as set out in the third column of that Annex, or to a group of Member States acting jointly as rapporteur Member State, as set out in the fourth column of that Annex, where applicable. In the latter case, no co-rapporteur is appointed.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

ANNEX

PART A

Allocation of the evaluation of active substances whose approval expires by 31 December 2018 at the latest

Active substance	Rapporteur Member State	Co-rapporteur Member State

1-methyl-cyclopropene	NL

2,4-DB	BE	EL
Acetamiprid	NL	ES
Alpha-cypermethrin	BE	EL
Amidosulfuron	FI	HR
Ampelomyces quisqualis Strain: AQ 10	FR	DE
Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713	DE	DK
Beflubutamid	DE	LT
Benalaxyl	RO	PT
Benthiavalicarb	PL	FR
Benzoic acid	HU	NL
Beta-cyfluthrin	DE	HU
Bifenazate	SE	IT
Bifenox	PL	BE
Bitertanol	SE	CZ
Boscalid	SK	FR
Bromoxynil	FR	DE
Captan	AT	IT
Carbendazim	DE	SI
Carfentrazone ethyl	BE	FR
Carvone	NL	SE
Chloridazon	DE	PL
Chlorothalonil	NL	BE
Chlorotoluron	BG	FR
Chlorpropham	NL	ES
Chlorpyrifos	ES	PL
Chlorpyrifos-methyl	ES	PL
Clodinafop	EL	DE
Clofentezine	ES	NL
Clomazone	DK	DE
Clopyralid	FI	PL
Clothianidin	DE	ES
Coniothyrium minitans Strain CON/M/91-08 (DSM 9660)	NL	EE
Copper compounds	FR	DE
Cyazofamid	FR	LV
Cyfluthrin	DE	HU
Cypermethrin	BE	DE
Cyprodinil	FR	BG
Daminozide	CZ	HU

Deltamethrin	AT	SE

Desmedipham	FI	DK
Dicamba	DK	RO
Dichlorprop-P	IE	PL
Difenoconazole	ES	UK
Diflubenzuron	EL	SK

Diflufenican	CZ

Dimethenamid-P	DE	BG
Dimethoate	IT	BG

Dimethomorph	NL	DE

Dimoxystrobin	HU	IE
Diuron	DE	DK
Ethephon	NL	PL
Ethofumesate	AT	DK
Ethoprophos	IT	IE
Ethoxysulfuron	IT	AT
Etoxazole	EL	UK
Fenamidone	CZ	FR
Fenamiphos	EL	CY
Fenoxaprop-P	AT	FI
Fenpropidin	CZ	DE
Fipronil	AT	NL
Flazasulfuron	ES	FR
Fludioxonil	FR	ES
Flufenacet	PL	FR

Fluoxastrobin	DE

Flurtamone	CZ	IE
Folpet	AT	IT
Foramsulfuron	FI	SK
Forchlorfenuron	ES	EL
Formetanate	ES	EL
Fosetyl	FR	EE
Fosthiazate	DE	EL
Gliocladium catenulatum Strain: J1446	HU	NL
Glufosinate	DE	FR
Imazamox	FR	IT
Imazaquin	BE	IE
Imazosulfuron	SI	FI
Indoxacarb	FR	ES
Iodosulfuron	SE	FI
Ioxynil	FR	AT
Iprodione	FR	BE
Isoxaflutole	IT	SI
Laminarin	NL	FR
Lenacil	BE	AT
Linuron	IT	DE
Maleic hydrazide	DK	BE

Mancozeb	EL

Maneb	IT	UK
MCPA	PL	NL
MCPB	PL	NL
Mecoprop	PL	IE

Mecoprop-P	UK	IE

Mepanipyrim	BE	EL
Mesosulfuron	FR	PL
Mesotrione	UK	BE
Metconazole	BE	UK

Methiocarb	DE
Methoxyfenozide	SK

Metiram	IT	UK
Metrafenone	LV	SK
Metribuzin	EE	DE
Milbemectin	DE	NL
Molinate	EL	PT
Nicosulfuron	LV	NL
Oxadiargyl	PL	IT
Oxadiazon	IT	ES
Oxamyl	IT	FR
Oxasulfuron	IT	AT
Paecilomyces lilacinus (Thom) Samson 1974 strain 251 (AGAL: No 89/030550)	HU	NL
Pendimethalin	NL	ES
Pethoxamid	AT	CZ
Phenmedipham	FI	DK
Phosmet	ES	EL
Picloram	PL	CZ
Picoxystrobin	CZ	RO

Pirimicarb	SE
Pirimiphos-methyl	FR

Propamocarb	PT	BE
Propiconazole	FI	UK
Propineb	IT	RO
Propoxycarbazone	SE	EE
Propyzamide	SE	UK
Prosulfocarb	PT	SE

Prothioconazole	PL

Pseudomonas chlororaphis Strain: MA 342	NL	DK
Pyraclostrobin	DE	HU
Pyrimethanil	CZ	AT
Pyriproxyfen	NL	ES
Quinoclamine	SE	DE
Quinoxyfen	UK	AT
Rimsulfuron	SI	FI
Silthiofam	IE	BE
S-metolachlor	DE	FR
Spinosad	NL	FR
Spodoptera exigua nuclear polyhedrosis virus	HU	NL
Tepraloxydim	ES	PL

Thiacloprid	DE

Thiamethoxam	FR	ES
Thiophanate-methyl	SE	FI
Thiram	FR	BE
Tolclofos-methyl	SE	DK
Tribenuron	SE	LV
Triclopyr	PL	HU
Trifloxystrobin	UK	EL
Trinexapac	LT	LV
Triticonazole	AT	UK
Tritosulfuron	SI	AT
Warfarin	SE	DE
Ziram	IT	MT
Zoxamide	LV	FR

PART B

Allocation of the evaluation of active substances whose approval expires after 31 December 2018 and not later than 31 December 2021

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.